Home » Topics » BioWorld Science

BioWorld Science
RSS

Gilead Sciences seeks Japanese approval of sofosbuvir/velpatasvir

May 22, 2018

New company Curevo to support GC Pharma's vaccine development work

May 22, 2018

Allergy Therapeutics reports promising topline results from phase II trial of Grass MATA MPL

May 22, 2018

Glenmark submits NDA for Ryaltris for seasonal allergic rhinitis

May 22, 2018

First-in-human study shows promise of SYNT-001 in pemphigus

May 22, 2018

MHRA clears 4D pharma to begin phase Ib study of MRx-0518

May 22, 2018

AstraZeneca files for Japanese approval of Forxiga for type 1 diabetes

May 22, 2018

Genentech presents first phase I data for BITS-7201A

May 22, 2018

Immunomedics submits BLA for sacituzumab govitecan for metastatic TNBC

May 22, 2018

Merck & Co.'s rVSV-ZEBOV Ebola vaccine deployed in Democratic Republic of Congo

May 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...